Issue 2/2010
Content (28 Articles)
Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy
Joseph A. Sparano, Etta D. Pisano, Julia R. White, Kelly K. Hunt, Eleftherios P. Mamounas, Edith A. Perez, Gabriel N. Hortobagyi, Julie R. Gralow, Robert L. Comis
Adjuvant therapy of triple negative breast cancer
Edith A. Perez, Alvaro Moreno-Aspitia, E. Aubrey Thompson, Cathy A. Andorfer
Combinatorial biomarker expression in breast cancer
Emad A. Rakha, Jorge S. Reis-Filho, Ian O. Ellis
Tai chi for breast cancer patients: a systematic review
Myeong Soo Lee, Tae-Young Choi, Edzard Ernst
SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells
Patrick Müller, Justin D. Crofts, Ben S. Newman, Laura C. Bridgewater, Chin-Yo Lin, Jan-Åke Gustafsson, Anders Ström
Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines
Ashok K. Chakraborty, Allison Welsh, Michael P. DiGiovanna
A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment
Jue Wang, Tian-Song Xia, Xiao-An Liu, Qiang Ding, Qing Du, Hong Yin, Shui Wang
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery
Evangelia-Ourania Fourkala, Cornelia Hauser-Kronberger, Sophia Apostolidou, Matthew Burnell, Allison Jones, Johannes Grall, Roland Reitsamer, Heidi Fiegl, Ian Jacobs, Usha Menon, Martin Widschwendter
Estrogen receptor α attenuates transforming growth factor-β signaling in breast cancer cells independent from agonistic and antagonistic ligands
Matthias B. Stope, Simone L. Popp, Cornelius Knabbe, Miriam B. Buck
Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor α in T47D breast cancer cells
YenHao Chen, KuangTzu Huang, KuanHui E. Chen, Ameae M. Walker
Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model
D. Fuentes, J. Avellanet, A. Garcia, N. Iglesias, M. R. Gabri, D. F. Alonso, A. M. Vazquez, R. Perez, E. Montero
The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding
Stefania Millevoi, Sandra Bernat, Dominique Telly, Françoise Fouque, Laurence Gladieff, Gilles Favre, Stéphan Vagner, Christine Toulas
The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells
Arend Brinkman, Danielle de Jong, Sietske Tuinman, Najat Azaouagh, Ton van Agthoven, Lambert C. J. Dorssers
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma
Jennifer Dunlap, Claudia Le, Arielle Shukla, Janice Patterson, Ajia Presnell, Michael C. Heinrich, Christopher L. Corless, Megan L. Troxell
Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor
Cemal Ulusoy, Ilknur Kepenekci, Kenan Kose, Semih Aydıntug, Ragıp Cam
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women
T. Cigler, D. Tu, M. J. Yaffe, B. Findlay, S. Verma, D. Johnston, H. Richardson, H. Hu, S. Qi, P. E. Goss
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy
Aditya Bardia, Vered Stearns
Outcome of axillary staging in early breast cancer: a meta-analysis
Malcolm R. Kell, John P. Burke, Mitchel Barry, Monica Morrow
The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer
Diane M. Renz, Joachim Böttcher, Pascal A. T. Baltzer, Matthias Dietzel, Tibor Vag, Mieczyslaw Gajda, Oumar Camara, Ingo B. Runnebaum, Werner A. Kaiser
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Ruth E. Board, Andrew M. Wardley, J. Michael Dixon, Anne C. Armstrong, Sacha Howell, Lorna Renshaw, Emma Donald, Alastair Greystoke, Malcolm Ranson, Andrew Hughes, Caroline Dive
Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review
Ying-Hua Yu, Chi Liang, Xi-Zi Yuan
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer
Gottfried E. Konecny, Giovanni Pauletti, Michael Untch, He-Jing Wang, Volker Möbus, Walther Kuhn, Christoph Thomssen, Nadia Harbeck, Ling Wang, Sophia Apple, Fritz Jänicke, Dennis J. Slamon
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
Lisa Rydén, Karin Jirström, Monica Haglund, Olle Stål, Mårten Fernö
Computer-aided detection in full-field digital mammography in a clinical population: performance of radiologist and technologists
Frank J. H. M. van den Biggelaar, Alphons G. H. Kessels, Jos M. A. van Engelshoven, Carla Boetes, Karin Flobbe
Comments on “Computer-aided detection in full-field digital mammography in a clinical population: performance of radiologist and technologists”
Matthew T. Freedman
P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case–control studies
Zhizhong Zhang, Meilin Wang, Dongmei Wu, Miaomiao Wang, Na Tong, Yuanyuan Tian, Zhengdong Zhang
Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva
Christine Bouchardy, Massimo Usel, Helena M. Verkooijen, Gérald Fioretta, Simone Benhamou, Isabelle Neyroud-Caspar, Robin Schaffar, Georges Vlastos, Yves Wespi, Peter Schäfer, Elisabetta Rapiti